Area of research
Neurology · Physiology
Research interest
Research interests include Amyotrophic Lateral Sclerosis Research, Alzheimer's disease research and treatments, Dementia and Cognitive Impairment Research, and Parkinson's Disease Mechanisms and Treatments.
Transferability of European-derived Alzheimer’s disease polygenic risk scores across multiancestry populations
Machine learning in Alzheimer’s disease genetics
Cerebrovascular Reactivity at Rest and Its Association With Cognitive Function in People With Genetic Frontotemporal Dementia
Distinct proteomic CSF profiles in genetic frontotemporal lobar degeneration
Executive Function Deficits in Genetic Frontotemporal Dementia
Thalamus involvement in genetic frontotemporal dementia assessed using structural and diffusion MRI: a GENFI study
Cellular signatures underlying functional resilience in presymptomatic frontotemporal dementia
Extending the phenotypic spectrum assessed by the CDR plus NACC FTLD in genetic frontotemporal dementia
X‐chromosome-wide association study for Alzheimer’s disease
Genetic Associations Between Modifiable Risk Factors and Alzheimer Disease
Incidence of Syndromes Associated With Frontotemporal Lobar Degeneration in 9 European Countries
Multiancestry analysis of the HLA locus in Alzheimer’s and Parkinson’s diseases uncovers a shared adaptive immune response mediated by <i>HLA-DRB1*04</i> subtypes
Frequency and phenotypic spectrum of spinocerebellar ataxia <scp>27B</scp> and other genetic ataxias in a Spanish cohort of late‐onset cerebellar ataxia
A longitudinal analysis of cerebral blood flow changes in genetic frontotemporal Dementia: Results from genfi
Examining longitudinal changes of disease severity scores in familial forms of frontotemporal dementia within the GENFI cohort
Developing a mass spectrometric assay to measure granulin peptides in CSF for progranulin‐associated frontotemporal dementia
A longitudinal analysis of the frontotemporal dementia rating scale as a sensitive measure of disease trajectory
Author Correction: Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores
Genome-wide meta-analysis for Alzheimer’s disease cerebrospinal fluid biomarkers
Network structure and transcriptomic vulnerability shape atrophy in frontotemporal dementia
Neurodevelopmental effects of genetic frontotemporal dementia in young adult mutation carriers
Frequency and Longitudinal Course of Motor Signs in Genetic Frontotemporal Dementia
Protective association of <i>HLA‐DRB1</i>*04 subtypes in neurodegenerative diseases implicates acetylated tau PHF6 sequences
Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores
Neuronal pentraxin 2: a synapse-derived CSF biomarker in genetic frontotemporal dementia
Brain functional network integrity sustains cognitive function despite atrophy in presymptomatic genetic frontotemporal dementia
Early symptoms in symptomatic and preclinical genetic frontotemporal lobar degeneration
Age at symptom onset and death and disease duration in genetic frontotemporal dementia: an international retrospective cohort study
A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity
A Comprehensive Resource for Induced Pluripotent Stem Cells from Patients with Primary Tauopathies